ESMO 2022 Conference Coverage


 

ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC

67 views
September 30, 2022
Comments 0
Login to view comments. Click here to Login